XPOVIO
- Product NDC
- 72237-102
- Requested package NDC
- 72237-102-02
- 11-digit product format
- 722370102
- Labeler code
- 72237
- Product ID
- 72237-102_5e9b366c-3fc4-4178-bb80-687e21f9beff
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- selinexor
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Karyopharm Therapeutics Inc.
- Application
- NDA212306
- Marketing category
- NDA
- Marketing start
- 2021-05-19
- Substance
- SELINEXOR
- Active strength
- 40 mg/1
- Pharmacologic classes
- Nuclear Export Inhibitor [EPC], Nuclear Export Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N212306-001 | XPOVIO | SELINEXOR | 20MG | TABLET / ORAL | RLD | 2019-07-03 | |
| N212306-002 | XPOVIO | SELINEXOR | 40MG | TABLET / ORAL | RLD | 2021-04-15 | |
| N212306-003 | XPOVIO | SELINEXOR | 50MG | TABLET / ORAL | RLD | 2021-04-15 | |
| N212306-004 | XPOVIO | SELINEXOR | 60MG | TABLET / ORAL | RLD, RS | 2021-04-15 | |
| N212306-005 | XPOVIO | SELINEXOR | 10MG | TABLET / ORAL | RLD | 2025-03-10 | |
| N212306-006 | XPOVIO | SELINEXOR | 80MG | TABLET / ORAL | RLD | 2025-10-20 |
Orange Book patents#
| Application-product | Patent | Expiration | Use code | Coverage / status | Submission date |
|---|---|---|---|---|---|
| N212306-001 | 10544108 | 2032-07-26 | U-2584 | 2020-02-24 | |
| N212306-001 | 10544108 | 2032-07-26 | U-3018 | 2020-02-24 | |
| N212306-001 | 11034660 | 2032-07-26 | U-2584 | 2021-07-14 | |
| N212306-001 | 11034660 | 2032-07-26 | U-3018 | 2021-07-14 | |
| N212306-001 | 11787771 | 2032-07-26 | U-2584 | 2023-11-15 | |
| N212306-001 | 11787771 | 2032-07-26 | U-2855 | 2023-11-15 | |
| N212306-001 | 11787771 | 2032-07-26 | U-3018 | 2023-11-15 | |
| N212306-001 | 12291508 | 2032-07-26 | U-2584 | 2025-06-04 | |
| N212306-001 | 12291508 | 2032-07-26 | U-3018 | 2025-06-04 | |
| N212306-001 | 9079865 | 2032-07-26 | U-2584 | 2019-07-31 | |
| N212306-001 | 9079865 | 2032-07-26 | U-3018 | 2019-07-31 | |
| N212306-001 | 9714226 | 2032-07-26 | Drug substance, Drug product | 2019-07-31 | |
| N212306-001 | 8999996 | 2033-07-03 | Drug substance, Drug product | 2019-07-31 | |
| N212306-001 | 10519139 | 2035-08-14 | U-2584 | Drug substance, Drug product | 2020-01-27 |
| N212306-001 | 10519139 | 2035-08-14 | U-3018 | Drug substance, Drug product | 2020-01-27 |
| N212306-001 | 11746102 | 2035-08-14 | U-2584 | 2023-10-04 | |
| N212306-001 | 11746102 | 2035-08-14 | U-3018 | 2023-10-04 | |
| N212306-001 | 11753401 | 2035-08-14 | U-2584 | Drug product | 2023-10-11 |
| N212306-001 | 11753401 | 2035-08-14 | U-3018 | Drug product | 2023-10-11 |
| N212306-001 | 11807629 | 2035-08-14 | Drug substance, Drug product | 2023-12-06 | |
| N212306-002 | 10544108 | 2032-07-26 | U-2584 | 2021-07-19 | |
| N212306-002 | 10544108 | 2032-07-26 | U-3018 | 2021-07-19 | |
| N212306-002 | 11034660 | 2032-07-26 | U-2584 | 2021-07-14 | |
| N212306-002 | 11034660 | 2032-07-26 | U-3018 | 2021-07-14 | |
| N212306-002 | 11787771 | 2032-07-26 | U-2584 | 2023-11-15 | |
| N212306-002 | 11787771 | 2032-07-26 | U-3018 | 2023-11-15 | |
| N212306-002 | 12291508 | 2032-07-26 | U-2584 | 2025-06-04 | |
| N212306-002 | 12291508 | 2032-07-26 | U-3018 | 2025-06-04 | |
| N212306-002 | 9079865 | 2032-07-26 | U-2584 | 2021-07-19 | |
| N212306-002 | 9079865 | 2032-07-26 | U-3018 | 2021-07-19 | |
| N212306-002 | 9714226 | 2032-07-26 | Drug substance, Drug product | 2021-07-19 | |
| N212306-002 | 8999996 | 2033-07-03 | Drug substance, Drug product | 2021-07-19 | |
| N212306-002 | 10519139 | 2035-08-14 | U-2584 | Drug substance, Drug product | 2021-07-19 |
| N212306-002 | 10519139 | 2035-08-14 | U-3018 | Drug substance, Drug product | 2021-07-19 |
| N212306-002 | 11746102 | 2035-08-14 | U-2584 | 2023-10-04 | |
| N212306-002 | 11746102 | 2035-08-14 | U-3018 | 2023-10-04 | |
| N212306-002 | 11753401 | 2035-08-14 | U-2584 | Drug product | 2023-10-11 |
| N212306-002 | 11753401 | 2035-08-14 | U-3018 | Drug product | 2023-10-11 |
| N212306-002 | 11807629 | 2035-08-14 | Drug substance, Drug product | 2023-12-06 | |
| N212306-003 | 10544108 | 2032-07-26 | U-2584 | 2021-07-19 | |
| N212306-003 | 10544108 | 2032-07-26 | U-3018 | 2021-07-19 | |
| N212306-003 | 11034660 | 2032-07-26 | U-2584 | 2021-07-14 | |
| N212306-003 | 11034660 | 2032-07-26 | U-3018 | 2021-07-14 | |
| N212306-003 | 11787771 | 2032-07-26 | U-2584 | 2023-11-15 | |
| N212306-003 | 11787771 | 2032-07-26 | U-3018 | 2023-11-15 | |
| N212306-003 | 12291508 | 2032-07-26 | U-2584 | 2025-06-04 | |
| N212306-003 | 12291508 | 2032-07-26 | U-3018 | 2025-06-04 | |
| N212306-003 | 9079865 | 2032-07-26 | U-2584 | 2021-07-19 | |
| N212306-003 | 9079865 | 2032-07-26 | U-3018 | 2021-07-19 | |
| N212306-003 | 9714226 | 2032-07-26 | Drug substance, Drug product | 2021-07-19 | |
| N212306-003 | 8999996 | 2033-07-03 | Drug substance, Drug product | 2021-07-19 | |
| N212306-003 | 10519139 | 2035-08-14 | U-2584 | Drug substance, Drug product | 2021-07-19 |
| N212306-003 | 10519139 | 2035-08-14 | U-3018 | Drug substance, Drug product | 2021-07-19 |
| N212306-003 | 11746102 | 2035-08-14 | U-2584 | 2023-10-04 | |
| N212306-003 | 11746102 | 2035-08-14 | U-3018 | 2023-10-04 | |
| N212306-003 | 11753401 | 2035-08-14 | U-2584 | Drug product | 2023-10-11 |
| N212306-003 | 11753401 | 2035-08-14 | U-3018 | Drug product | 2023-10-11 |
| N212306-003 | 11807629 | 2035-08-14 | Drug substance, Drug product | 2023-12-06 | |
| N212306-004 | 10544108 | 2032-07-26 | U-2584 | 2021-07-19 | |
| N212306-004 | 10544108 | 2032-07-26 | U-3018 | 2021-07-19 | |
| N212306-004 | 11034660 | 2032-07-26 | U-2584 | 2021-07-14 | |
| N212306-004 | 11034660 | 2032-07-26 | U-3018 | 2021-07-14 | |
| N212306-004 | 11787771 | 2032-07-26 | U-2584 | 2023-11-15 | |
| N212306-004 | 11787771 | 2032-07-26 | U-3018 | 2023-11-15 | |
| N212306-004 | 12291508 | 2032-07-26 | U-2584 | 2025-06-04 | |
| N212306-004 | 12291508 | 2032-07-26 | U-3018 | 2025-06-04 | |
| N212306-004 | 9079865 | 2032-07-26 | U-2584 | 2021-07-19 | |
| N212306-004 | 9079865 | 2032-07-26 | U-3018 | 2021-07-19 | |
| N212306-004 | 9714226 | 2032-07-26 | Drug substance, Drug product | 2021-07-19 | |
| N212306-004 | 8999996 | 2033-07-03 | Drug substance, Drug product | 2021-07-19 | |
| N212306-004 | 10519139 | 2035-08-14 | U-2584 | Drug substance, Drug product | 2021-07-19 |
| N212306-004 | 10519139 | 2035-08-14 | U-3018 | Drug substance, Drug product | 2021-07-19 |
| N212306-004 | 11746102 | 2035-08-14 | U-2584 | 2023-10-04 | |
| N212306-004 | 11746102 | 2035-08-14 | U-3018 | 2023-10-04 | |
| N212306-004 | 11753401 | 2035-08-14 | U-2584 | Drug product | 2023-10-11 |
| N212306-004 | 11753401 | 2035-08-14 | U-3018 | Drug product | 2023-10-11 |
| N212306-004 | 11807629 | 2035-08-14 | Drug substance, Drug product | 2023-12-06 | |
| N212306-005 | 10544108 | 2032-07-26 | U-2584 | 2025-04-08 | |
| N212306-005 | 10544108 | 2032-07-26 | U-3018 | 2025-04-08 | |
| N212306-005 | 11034660 | 2032-07-26 | U-2584 | 2025-04-08 |
Orange Book exclusivity#
| Application-product | Exclusivity code | Expiration |
|---|---|---|
| N212306-001 | ODE-257 | 2026-07-03 |
| N212306-001 | ODE-310 | 2027-06-22 |
| N212306-001 | ODE-346 | 2027-12-18 |
| N212306-002 | ODE* | 2026-07-03 |
| N212306-002 | ODE* | 2027-06-22 |
| N212306-002 | ODE* | 2027-12-18 |
| N212306-003 | ODE* | 2026-07-03 |
| N212306-003 | ODE* | 2027-06-22 |
| N212306-003 | ODE* | 2027-12-18 |
| N212306-004 | ODE* | 2026-07-03 |
| N212306-004 | ODE* | 2027-06-22 |
| N212306-004 | ODE* | 2027-12-18 |
| N212306-005 | ODE* | 2026-07-03 |
| N212306-005 | ODE* | 2027-06-22 |
| N212306-005 | ODE* | 2027-12-18 |
| N212306-006 | ODE* | 2026-07-03 |
| N212306-006 | ODE* | 2027-12-18 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | N212306-001 | XPOVIO | 20MG | TABLET / ORAL | RLD | 2019-07-03 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N212306-002 | XPOVIO | 40MG | TABLET / ORAL | RLD | 2021-04-15 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N212306-003 | XPOVIO | 50MG | TABLET / ORAL | RLD | 2021-04-15 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N212306-004 | XPOVIO | 60MG | TABLET / ORAL | RLD, RS | 2021-04-15 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N212306-005 | XPOVIO | 10MG | TABLET / ORAL | RLD | 2025-03-10 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N212306-006 | XPOVIO | 80MG | TABLET / ORAL | RLD | 2025-10-20 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | N212306-001 | XPOVIO | 20MG | TABLET / ORAL | RLD | 2019-07-03 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N212306-002 | XPOVIO | 40MG | TABLET / ORAL | RLD | 2021-04-15 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N212306-003 | XPOVIO | 50MG | TABLET / ORAL | RLD | 2021-04-15 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N212306-004 | XPOVIO | 60MG | TABLET / ORAL | RLD, RS | 2021-04-15 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N212306-005 | XPOVIO | 10MG | TABLET / ORAL | RLD | 2025-03-10 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N212306-006 | XPOVIO | 80MG | TABLET / ORAL | RLD | 2025-10-20 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | N212306-001 | XPOVIO | 20MG | TABLET / ORAL | RLD | 2019-07-03 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N212306-002 | XPOVIO | 40MG | TABLET / ORAL | RLD | 2021-04-15 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N212306-003 | XPOVIO | 50MG | TABLET / ORAL | RLD | 2021-04-15 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N212306-004 | XPOVIO | 60MG | TABLET / ORAL | RLD, RS | 2021-04-15 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N212306-005 | XPOVIO | 10MG | TABLET / ORAL | RLD | 2025-03-10 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N212306-006 | XPOVIO | 80MG | TABLET / ORAL | RLD | 2025-10-20 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N212306-001 | XPOVIO | 20MG | TABLET / ORAL | RLD | 2019-07-03 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N212306-002 | XPOVIO | 40MG | TABLET / ORAL | RLD | 2021-04-15 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N212306-003 | XPOVIO | 50MG | TABLET / ORAL | RLD | 2021-04-15 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N212306-004 | XPOVIO | 60MG | TABLET / ORAL | RLD, RS | 2021-04-15 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N212306-005 | XPOVIO | 10MG | TABLET / ORAL | RLD | 2025-03-10 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N212306-006 | XPOVIO | 80MG | TABLET / ORAL | RLD | 2025-10-20 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N212306-001 | XPOVIO | 20MG | TABLET / ORAL | RLD | 2019-07-03 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N212306-002 | XPOVIO | 40MG | TABLET / ORAL | RLD | 2021-04-15 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N212306-003 | XPOVIO | 50MG | TABLET / ORAL | RLD | 2021-04-15 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N212306-004 | XPOVIO | 60MG | TABLET / ORAL | RLD, RS | 2021-04-15 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N212306-005 | XPOVIO | 10MG | TABLET / ORAL | RLD | 2025-03-10 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N212306-001 | XPOVIO | 20MG | TABLET / ORAL | RLD | 2019-07-03 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N212306-002 | XPOVIO | 40MG | TABLET / ORAL | RLD | 2021-04-15 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N212306-003 | XPOVIO | 50MG | TABLET / ORAL | RLD | 2021-04-15 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N212306-004 | XPOVIO | 60MG | TABLET / ORAL | RLD, RS | 2021-04-15 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N212306-001 | XPOVIO | 20MG | TABLET / ORAL | RLD | 2019-07-03 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N212306-002 | XPOVIO | 40MG | TABLET / ORAL | RLD | 2021-04-15 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N212306-003 | XPOVIO | 50MG | TABLET / ORAL | RLD | 2021-04-15 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N212306-004 | XPOVIO | 60MG | TABLET / ORAL | RLD, RS | 2021-04-15 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N212306-001 | XPOVIO | 20MG | TABLET / ORAL | RLD | 2019-07-03 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N212306-002 | XPOVIO | 40MG | TABLET / ORAL | RLD | 2021-04-15 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N212306-003 | XPOVIO | 50MG | TABLET / ORAL | RLD | 2021-04-15 | 03ed91905a0d… |
Observed Orange Book patent history#
| Captured | Edition | Application-product | Patent | Expiration | Use code | Coverage / status | Submission date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | N212306-001 | 10544108 | 2032-07-26 | U-2584 | 2020-02-24 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N212306-001 | 10544108 | 2032-07-26 | U-3018 | 2020-02-24 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N212306-001 | 11034660 | 2032-07-26 | U-2584 | 2021-07-14 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N212306-001 | 11034660 | 2032-07-26 | U-3018 | 2021-07-14 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N212306-001 | 11787771 | 2032-07-26 | U-2855 | 2023-11-15 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N212306-001 | 11787771 | 2032-07-26 | U-2584 | 2023-11-15 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N212306-001 | 11787771 | 2032-07-26 | U-3018 | 2023-11-15 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N212306-001 | 12291508 | 2032-07-26 | U-3018 | 2025-06-04 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N212306-001 | 12291508 | 2032-07-26 | U-2584 | 2025-06-04 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N212306-001 | 9079865 | 2032-07-26 | U-2584 | 2019-07-31 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N212306-001 | 9079865 | 2032-07-26 | U-3018 | 2019-07-31 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N212306-001 | 9714226 | 2032-07-26 | Drug substance, Drug product | 2019-07-31 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N212306-001 | 8999996 | 2033-07-03 | Drug substance, Drug product | 2019-07-31 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N212306-001 | 10519139 | 2035-08-14 | U-2584 | Drug substance, Drug product | 2020-01-27 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N212306-001 | 10519139 | 2035-08-14 | U-3018 | Drug substance, Drug product | 2020-01-27 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N212306-001 | 11746102 | 2035-08-14 | U-2584 | 2023-10-04 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N212306-001 | 11746102 | 2035-08-14 | U-3018 | 2023-10-04 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N212306-001 | 11753401 | 2035-08-14 | U-2584 | Drug product | 2023-10-11 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N212306-001 | 11753401 | 2035-08-14 | U-3018 | Drug product | 2023-10-11 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N212306-001 | 11807629 | 2035-08-14 | Drug substance, Drug product | 2023-12-06 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N212306-002 | 10544108 | 2032-07-26 | U-3018 | 2021-07-19 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N212306-002 | 10544108 | 2032-07-26 | U-2584 | 2021-07-19 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N212306-002 | 11034660 | 2032-07-26 | U-2584 | 2021-07-14 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N212306-002 | 11034660 | 2032-07-26 | U-3018 | 2021-07-14 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N212306-002 | 11787771 | 2032-07-26 | U-3018 | 2023-11-15 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N212306-002 | 11787771 | 2032-07-26 | U-2584 | 2023-11-15 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N212306-002 | 12291508 | 2032-07-26 | U-2584 | 2025-06-04 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N212306-002 | 12291508 | 2032-07-26 | U-3018 | 2025-06-04 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N212306-002 | 9079865 | 2032-07-26 | U-2584 | 2021-07-19 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N212306-002 | 9079865 | 2032-07-26 | U-3018 | 2021-07-19 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N212306-002 | 9714226 | 2032-07-26 | Drug substance, Drug product | 2021-07-19 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N212306-002 | 8999996 | 2033-07-03 | Drug substance, Drug product | 2021-07-19 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N212306-002 | 10519139 | 2035-08-14 | U-2584 | Drug substance, Drug product | 2021-07-19 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N212306-002 | 10519139 | 2035-08-14 | U-3018 | Drug substance, Drug product | 2021-07-19 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N212306-002 | 11746102 | 2035-08-14 | U-2584 | 2023-10-04 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N212306-002 | 11746102 | 2035-08-14 | U-3018 | 2023-10-04 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N212306-002 | 11753401 | 2035-08-14 | U-2584 | Drug product | 2023-10-11 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N212306-002 | 11753401 | 2035-08-14 | U-3018 | Drug product | 2023-10-11 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N212306-002 | 11807629 | 2035-08-14 | Drug substance, Drug product | 2023-12-06 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N212306-003 | 10544108 | 2032-07-26 | U-2584 | 2021-07-19 | 84e616aacf4f… |
Observed Orange Book exclusivity history#
| Captured | Edition | Application-product | Exclusivity code | Expiration | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | N212306-001 | ODE-257 | 2026-07-03 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N212306-001 | ODE-310 | 2027-06-22 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N212306-001 | ODE-346 | 2027-12-18 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N212306-002 | ODE* | 2026-07-03 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N212306-002 | ODE* | 2027-06-22 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N212306-002 | ODE* | 2027-12-18 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N212306-003 | ODE* | 2026-07-03 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N212306-003 | ODE* | 2027-06-22 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N212306-003 | ODE* | 2027-12-18 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N212306-004 | ODE* | 2026-07-03 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N212306-004 | ODE* | 2027-06-22 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N212306-004 | ODE* | 2027-12-18 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N212306-005 | ODE* | 2026-07-03 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N212306-005 | ODE* | 2027-06-22 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N212306-005 | ODE* | 2027-12-18 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N212306-006 | ODE* | 2026-07-03 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N212306-006 | ODE* | 2027-12-18 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | N212306-001 | ODE-257 | 2026-07-03 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N212306-001 | ODE-310 | 2027-06-22 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N212306-001 | ODE-346 | 2027-12-18 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N212306-002 | ODE* | 2026-07-03 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N212306-002 | ODE* | 2027-06-22 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N212306-002 | ODE* | 2027-12-18 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N212306-003 | ODE* | 2026-07-03 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N212306-003 | ODE* | 2027-06-22 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N212306-003 | ODE* | 2027-12-18 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N212306-004 | ODE* | 2026-07-03 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N212306-004 | ODE* | 2027-06-22 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N212306-004 | ODE* | 2027-12-18 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N212306-005 | ODE* | 2026-07-03 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N212306-005 | ODE* | 2027-06-22 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N212306-005 | ODE* | 2027-12-18 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N212306-006 | ODE* | 2026-07-03 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N212306-006 | ODE* | 2027-12-18 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | N212306-001 | ODE-257 | 2026-07-03 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N212306-001 | ODE-310 | 2027-06-22 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N212306-001 | ODE-346 | 2027-12-18 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N212306-002 | ODE* | 2026-07-03 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N212306-002 | ODE* | 2027-06-22 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N212306-002 | ODE* | 2027-12-18 | 011fe1cb6892… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- XPOVIO
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| SELINEXOR | 40 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 31TZ62FO8F | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 2178395 | Internal RxNorm lookup |
| 2178402 | Internal RxNorm lookup |
| 2178406 | Internal RxNorm lookup |
| 2178407 | Internal RxNorm lookup |
| 2382989 | Internal RxNorm lookup |
| 2382990 | Internal RxNorm lookup |
| 2548732 | Internal RxNorm lookup |
| 2548733 | Internal RxNorm lookup |
| 2548735 | Internal RxNorm lookup |
| 2548736 | Internal RxNorm lookup |
| 2548738 | Internal RxNorm lookup |
| 2548739 | Internal RxNorm lookup |
| 2548741 | Internal RxNorm lookup |
| 2548742 | Internal RxNorm lookup |
| 2548762 | Internal RxNorm lookup |
| 2548763 | Internal RxNorm lookup |
| 2548765 | Internal RxNorm lookup |
| 2548766 | Internal RxNorm lookup |
| 2548767 | Internal RxNorm lookup |
| 2548768 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| f6dd2682-75a6-4863-90a8-a3197f6f78a8 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 864fad62-a3dc-47ff-8f78-4e9ac5e7bc1a | Product name | 1 | 20191002 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 72237-102-02 | XPOVIO | 4 in 1 CARTON | TABLET, FILM COATED | 4 | 18 | |
| 72237-102-06 | XPOVIO | 4 in 1 CARTON | TABLET, FILM COATED | 4 | 18 | |
| 72237-102-07 | XPOVIO | 4 in 1 CARTON | TABLET, FILM COATED | 4 | 18 | |
| 72237-102-12 | XPOVIO | 2 in 1 BLISTER PACK | TABLET, FILM COATED | 2 | 18 | |
| 72237-102-16 | XPOVIO | 2 in 1 BLISTER PACK | TABLET, FILM COATED | 2 | 18 | |
| 72237-102-17 | XPOVIO | 1 in 1 BLISTER PACK | TABLET, FILM COATED | 1 | 18 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 72237-102-02 | EA - Each | 72237-102 | 5cb59f20-c475-4ae7-8ece-7a062178e0b6 | 1 | 2021-05-05 |
| 72237-102-06 | EA - Each | 72237-102 | 39373238-a9f5-4ee0-9f43-8f99d31f0fb6 | 1 | 2021-05-05 |
| 72237-102-07 | EA - Each | 72237-102 | 85f3bee0-0fe8-4186-9224-9bbccce59bc7 | 1 | 2021-05-05 |
| 72237-102-12 | EA - Each | 72237-102 | d184bc67-e178-4f1e-8d0e-f77ce88c586e | 1 | 2021-05-05 |
| 72237-102-16 | EA - Each | 72237-102 | a796b497-02b1-42a5-a070-4c6bd0321ab8 | 1 | 2021-05-05 |
| 72237-102-17 | EA - Each | 72237-102 | 73500fa2-fc32-4b0d-875a-693fab6895fc | 1 | 2021-05-05 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| XPOVIO | SELINEXOR | Karyopharm Therapeutics Inc. | f6dd2682-75a6-4863-90a8-a3197f6f78a8 | 2026-05-12 | Warnings, Adverse reactions | 212306 NDA212306 72237-102-02 72237-102 72237010202 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 2708339 | {16 (selinexor 10 MG Oral Tablet [Xpovio]) } Pack [Xpovio 40 MG Once Weekly Carton-10 MG Tablet] | BPCK | f6dd2682-75a6-4863-90a8-a3197f6f78a8 | 18 |
| 2382990 | {24 (selinexor 20 MG Oral Tablet [Xpovio]) } Pack [Xpovio 60 MG Twice Weekly (120 MG total weekly dose) Carton] | BPCK | f6dd2682-75a6-4863-90a8-a3197f6f78a8 | 18 |
| 2178407 | {32 (selinexor 20 MG Oral Tablet [Xpovio]) } Pack [Xpovio 80 MG Twice Weekly (160 MG total weekly dose) Carton] | BPCK | f6dd2682-75a6-4863-90a8-a3197f6f78a8 | 18 |
| 2548769 | {4 (selinexor 40 MG Oral Tablet [Xpovio]) } Pack [Xpovio 40 MG Once Weekly Carton-40 MG Tablet] | BPCK | f6dd2682-75a6-4863-90a8-a3197f6f78a8 | 18 |
| 2548736 | {4 (selinexor 60 MG Oral Tablet [Xpovio]) } Pack [Xpovio 60 MG Once Weekly Carton-60 MG Tablet] | BPCK | f6dd2682-75a6-4863-90a8-a3197f6f78a8 | 18 |
| 2730156 | {4 (selinexor 80 MG Oral Tablet [Xpovio]) } Pack [Xpovio 80 MG Once Weekly Carton-80 MG Tablet] | BPCK | f6dd2682-75a6-4863-90a8-a3197f6f78a8 | 18 |
| 2548767 | {8 (selinexor 40 MG Oral Tablet [Xpovio]) } Pack [Xpovio 40 MG Twice Weekly (80 MG total weekly dose- 40 MG Tablets) Carton] | BPCK | f6dd2682-75a6-4863-90a8-a3197f6f78a8 | 18 |
| 2548766 | {8 (selinexor 40 MG Oral Tablet [Xpovio]) } Pack [Xpovio 80 MG Once Weekly Carton-40 MG Tablets] | BPCK | f6dd2682-75a6-4863-90a8-a3197f6f78a8 | 18 |
| 2548742 | {8 (selinexor 50 MG Oral Tablet [Xpovio]) } Pack [Xpovio 100 MG Once Weekly Carton-50 MG Tablets] | BPCK | f6dd2682-75a6-4863-90a8-a3197f6f78a8 | 18 |
| 2708338 | {16 (selinexor 10 MG Oral Tablet) } Pack | GPCK | f6dd2682-75a6-4863-90a8-a3197f6f78a8 | 18 |
| 2382989 | {24 (selinexor 20 MG Oral Tablet) } Pack | GPCK | f6dd2682-75a6-4863-90a8-a3197f6f78a8 | 18 |
| 2178406 | {32 (selinexor 20 MG Oral Tablet) } Pack | GPCK | f6dd2682-75a6-4863-90a8-a3197f6f78a8 | 18 |
| 2548768 | {4 (selinexor 40 MG Oral Tablet) } Pack | GPCK | f6dd2682-75a6-4863-90a8-a3197f6f78a8 | 18 |
| 2548733 | {4 (selinexor 60 MG Oral Tablet) } Pack | GPCK | f6dd2682-75a6-4863-90a8-a3197f6f78a8 | 18 |
| 2730155 | {4 (selinexor 80 MG Oral Tablet) } Pack | GPCK | f6dd2682-75a6-4863-90a8-a3197f6f78a8 | 18 |
| 2548763 | {8 (selinexor 40 MG Oral Tablet) } Pack | GPCK | f6dd2682-75a6-4863-90a8-a3197f6f78a8 | 18 |
| 2548739 | {8 (selinexor 50 MG Oral Tablet) } Pack | GPCK | f6dd2682-75a6-4863-90a8-a3197f6f78a8 | 18 |
| 2708335 | selinexor 10 MG Oral Tablet | PSN | f6dd2682-75a6-4863-90a8-a3197f6f78a8 | 18 |
| 2548739 | selinexor 100 MG Weekly Dose Carton Pack, 50 MG oral Tablet 8 Count Pack | PSN | f6dd2682-75a6-4863-90a8-a3197f6f78a8 | 18 |
| 2178395 | selinexor 20 MG Oral Tablet | PSN | f6dd2682-75a6-4863-90a8-a3197f6f78a8 | 18 |
| 2548762 | selinexor 40 MG Oral Tablet | PSN | f6dd2682-75a6-4863-90a8-a3197f6f78a8 | 18 |
| 2708338 | selinexor 40 MG Weekly Dose Carton Pack, 10 MG oral Tablet 16 Count Pack | PSN | f6dd2682-75a6-4863-90a8-a3197f6f78a8 | 18 |
| 2548768 | selinexor 40 MG Weekly Dose Carton Pack, 40 MG oral Tablet 4 Count Pack | PSN | f6dd2682-75a6-4863-90a8-a3197f6f78a8 | 18 |
| 2548738 | selinexor 50 MG Oral Tablet | PSN | f6dd2682-75a6-4863-90a8-a3197f6f78a8 | 18 |
| 2548732 | selinexor 60 MG Oral Tablet | PSN | f6dd2682-75a6-4863-90a8-a3197f6f78a8 | 18 |
| 2382989 | selinexor 60 MG Twice Weekly (120 MG total weekly) Dose Carton Pack, 20 MG oral Tablet 24 Count Pack | PSN | f6dd2682-75a6-4863-90a8-a3197f6f78a8 | 18 |
| 2548733 | selinexor 60 MG Weekly Dose Carton Pack, 60 MG oral Tablet 4 Count Pack | PSN | f6dd2682-75a6-4863-90a8-a3197f6f78a8 | 18 |
| 2730152 | selinexor 80 MG Oral Tablet | PSN | f6dd2682-75a6-4863-90a8-a3197f6f78a8 | 18 |
| 2178406 | selinexor 80 MG Twice Weekly (160 MG total weekly) Dose Carton Pack, 20 MG oral Tablet 32 Count Pack | PSN | f6dd2682-75a6-4863-90a8-a3197f6f78a8 | 18 |
| 2730155 | selinexor 80 MG Weekly Dose (80 MG Tablet) Carton Pack | PSN | f6dd2682-75a6-4863-90a8-a3197f6f78a8 | 18 |
| 2548763 | selinexor 80 MG Weekly Dose Carton Pack, 40 MG oral Tablet 8 Count Pack | PSN | f6dd2682-75a6-4863-90a8-a3197f6f78a8 | 18 |
| 2708337 | Xpovio 10 MG Oral Tablet | PSN | f6dd2682-75a6-4863-90a8-a3197f6f78a8 | 18 |
| 2548742 | XPOVIO 100 MG Weekly Dose (50 MG Tablet) Carton Pack | PSN | f6dd2682-75a6-4863-90a8-a3197f6f78a8 | 18 |
| 2178402 | XPOVIO 20 MG Oral Tablet | PSN | f6dd2682-75a6-4863-90a8-a3197f6f78a8 | 18 |
| 2548765 | XPOVIO 40 MG Oral Tablet | PSN | f6dd2682-75a6-4863-90a8-a3197f6f78a8 | 18 |
| 2548767 | XPOVIO 40 MG Twice Weekly Dose (40 MG Tablets) Carton Pack | PSN | f6dd2682-75a6-4863-90a8-a3197f6f78a8 | 18 |
| 2708339 | XPOVIO 40 MG Weekly Dose (10 MG Tablet) Carton Pack | PSN | f6dd2682-75a6-4863-90a8-a3197f6f78a8 | 18 |
| 2548769 | XPOVIO 40 MG Weekly Dose (40 MG Tablet) Carton Pack | PSN | f6dd2682-75a6-4863-90a8-a3197f6f78a8 | 18 |
| 2548741 | XPOVIO 50 MG Oral Tablet | PSN | f6dd2682-75a6-4863-90a8-a3197f6f78a8 | 18 |
| 2548735 | XPOVIO 60 MG Oral Tablet | PSN | f6dd2682-75a6-4863-90a8-a3197f6f78a8 | 18 |
| 2382990 | XPOVIO 60 MG Twice Weekly (120 MG total weekly) Dose Carton Pack | PSN | f6dd2682-75a6-4863-90a8-a3197f6f78a8 | 18 |
| 2548736 | XPOVIO 60 MG Weekly Dose (60 MG Tablet) Carton Pack | PSN | f6dd2682-75a6-4863-90a8-a3197f6f78a8 | 18 |
| 2730154 | XPOVIO 80 MG Oral Tablet | PSN | f6dd2682-75a6-4863-90a8-a3197f6f78a8 | 18 |
| 2178407 | XPOVIO 80 MG Twice Weekly (160 MG total weekly) Dose Carton Pack | PSN | f6dd2682-75a6-4863-90a8-a3197f6f78a8 | 18 |
| 2548766 | XPOVIO 80 MG Weekly Dose (40 MG Tablets) Carton Pack | PSN | f6dd2682-75a6-4863-90a8-a3197f6f78a8 | 18 |
| 2730156 | XPOVIO 80 MG Weekly Dose (80 MG Tablet) Carton Pack | PSN | f6dd2682-75a6-4863-90a8-a3197f6f78a8 | 18 |
| 2708337 | selinexor 10 MG Oral Tablet [Xpovio] | SBD | f6dd2682-75a6-4863-90a8-a3197f6f78a8 | 18 |
| 2178402 | selinexor 20 MG Oral Tablet [Xpovio] | SBD | f6dd2682-75a6-4863-90a8-a3197f6f78a8 | 18 |
| 2548765 | selinexor 40 MG Oral Tablet [Xpovio] | SBD | f6dd2682-75a6-4863-90a8-a3197f6f78a8 | 18 |
| 2548741 | selinexor 50 MG Oral Tablet [Xpovio] | SBD | f6dd2682-75a6-4863-90a8-a3197f6f78a8 | 18 |
| 2548735 | selinexor 60 MG Oral Tablet [Xpovio] | SBD | f6dd2682-75a6-4863-90a8-a3197f6f78a8 | 18 |
| 2730154 | selinexor 80 MG Oral Tablet [Xpovio] | SBD | f6dd2682-75a6-4863-90a8-a3197f6f78a8 | 18 |
| 2708335 | selinexor 10 MG Oral Tablet | SCD | f6dd2682-75a6-4863-90a8-a3197f6f78a8 | 18 |
| 2178395 | selinexor 20 MG Oral Tablet | SCD | f6dd2682-75a6-4863-90a8-a3197f6f78a8 | 18 |
| 2548762 | selinexor 40 MG Oral Tablet | SCD | f6dd2682-75a6-4863-90a8-a3197f6f78a8 | 18 |
| 2548738 | selinexor 50 MG Oral Tablet | SCD | f6dd2682-75a6-4863-90a8-a3197f6f78a8 | 18 |
| 2548732 | selinexor 60 MG Oral Tablet | SCD | f6dd2682-75a6-4863-90a8-a3197f6f78a8 | 18 |
| 2730152 | selinexor 80 MG Oral Tablet | SCD | f6dd2682-75a6-4863-90a8-a3197f6f78a8 | 18 |
| 2548739 | selinexor 100 MG Weekly Dose Carton Pack, 4 Blister Cards, 2 Tablets Each | SY | f6dd2682-75a6-4863-90a8-a3197f6f78a8 | 18 |
| 2548763 | selinexor 40 MG Twice Weekly (80 MG total weekly) Dose Carton Pack, 4 Blister Cards, 2 Tablets Each | SY | f6dd2682-75a6-4863-90a8-a3197f6f78a8 | 18 |
| 2548768 | selinexor 40 MG Weekly Dose Carton Pack, 4 Blister Cards, 1 Tablet Each | SY | f6dd2682-75a6-4863-90a8-a3197f6f78a8 | 18 |
| 2708338 | selinexor 40 MG Weekly Dose Carton Pack, 4 Blister Cards, 4 Tablets Each | SY | f6dd2682-75a6-4863-90a8-a3197f6f78a8 | 18 |
| 2382989 | selinexor 60 MG Twice Weekly (120 MG total weekly) Dose Carton Pack, 4 Blister Cards, 6 Tablets Each | SY | f6dd2682-75a6-4863-90a8-a3197f6f78a8 | 18 |
| 2548733 | selinexor 60 MG Weekly Dose Carton Pack, 4 Blister Cards, 1 Tablet Each | SY | f6dd2682-75a6-4863-90a8-a3197f6f78a8 | 18 |
| 2178406 | selinexor 80 MG Twice Weekly (160 MG total weekly) Dose Carton Pack, 4 Blister Cards, 8 Tablets Each | SY | f6dd2682-75a6-4863-90a8-a3197f6f78a8 | 18 |
| 2730155 | selinexor 80 MG Weekly Dose Carton Pack, 4 Blister Cards, 1 Tablet Each | SY | f6dd2682-75a6-4863-90a8-a3197f6f78a8 | 18 |
| 2548763 | selinexor 80 MG Weekly Dose Carton Pack, 4 Blister Cards, 2 Tablets Each | SY | f6dd2682-75a6-4863-90a8-a3197f6f78a8 | 18 |
| 2708337 | Xpovio 10 MG Oral Tablet | SY | f6dd2682-75a6-4863-90a8-a3197f6f78a8 | 18 |
| 2548742 | Xpovio 100 MG Weekly Dose Carton Pack, 4 Blister Cards, 2 Tablets Each | SY | f6dd2682-75a6-4863-90a8-a3197f6f78a8 | 18 |
| 2178402 | Xpovio 20 MG Oral Tablet | SY | f6dd2682-75a6-4863-90a8-a3197f6f78a8 | 18 |
| 2548765 | Xpovio 40 MG Oral Tablet | SY | f6dd2682-75a6-4863-90a8-a3197f6f78a8 | 18 |
| 2548767 | Xpovio 40 MG Twice Weekly (80 MG total weekly) Dose Carton Pack, 4 Blister Cards, 2 Tablets Each | SY | f6dd2682-75a6-4863-90a8-a3197f6f78a8 | 18 |
| 2548769 | Xpovio 40 MG Weekly Dose Carton Pack, 4 Blister Cards, 1 Tablet Each | SY | f6dd2682-75a6-4863-90a8-a3197f6f78a8 | 18 |
| 2708339 | Xpovio 40 MG Weekly Dose Carton Pack, 4 Blister Cards, 4 Tablets Each | SY | f6dd2682-75a6-4863-90a8-a3197f6f78a8 | 18 |
| 2548741 | Xpovio 50 MG Oral Tablet | SY | f6dd2682-75a6-4863-90a8-a3197f6f78a8 | 18 |
| 2548735 | Xpovio 60 MG Oral Tablet | SY | f6dd2682-75a6-4863-90a8-a3197f6f78a8 | 18 |
| 2382990 | Xpovio 60 MG Twice Weekly (120 MG total weekly) Dose Carton Pack, 4 Blister Cards, 6 Tablets Each | SY | f6dd2682-75a6-4863-90a8-a3197f6f78a8 | 18 |
| 2548736 | Xpovio 60 MG Weekly Dose Carton Pack, 4 Blister Cards, 1 Tablet Each | SY | f6dd2682-75a6-4863-90a8-a3197f6f78a8 | 18 |
| 2730154 | Xpovio 80 MG Oral Tablet | SY | f6dd2682-75a6-4863-90a8-a3197f6f78a8 | 18 |
| 2178407 | Xpovio 80 MG Twice Weekly (160 MG total weekly) Dose Carton Pack, 4 Blister Cards, 8 Tablets Each | SY | f6dd2682-75a6-4863-90a8-a3197f6f78a8 | 18 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 72237-102-02 | 72237010202 | 4 BLISTER PACK in 1 CARTON (72237-102-02) / 2 TABLET, FILM COATED in 1 BLISTER PACK (72237-102-12) | 4 blister pack | 2021-05-19 | 0000-00-00 | No | No | Current |